Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 1, p. 31, doi. 10.3322/caac.20095
- By:
- Publication type:
- Article
Works matching IS 00079235 AND DT 2011 AND VI 61 AND IP 1
Results: 6
1
2
Elimination of cancer disparities via organizational transformation and community-driven approaches.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
3
Patients with nonovarian peritoneal carcinomatosis achieve long-term survival.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 1, p. 3, doi. 10.3322/caac.20101
- By:
- Publication type:
- Article
4
Self-management: Enabling and empowering patients living with cancer as a chronic illness.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 1, p. 50, doi. 10.3322/caac.20093
- By:
- Publication type:
- Article
5
Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 1, p. 1, doi. 10.3322/caac.20100
- By:
- Publication type:
- Article
6
Cancer screening in the United States, 2011.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 1, p. 8, doi. 10.3322/caac.20096
- By:
- Publication type:
- Article